Elevated levels of plasma homocysteine are associated with neurotoxicity

被引:25
作者
Bisschops, RHC
van der Graaf, Y
Mali, WPTM
van der Grond, J
机构
[1] Univ Utrecht, Med Ctr, Dept Radiol E01132, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands
关键词
MR spectroscopy; homocysteine; cardiovascular risk factors;
D O I
10.1016/j.atherosclerosis.2004.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of the present study is to investigate whether increased plasma homocysteine (tHcy) has an effect on the cerebral metabolic concentrations, reflecting neurotoxicity, measured with Magnetic Resonance Spectroscopy (MRS). Methods: One hundred and thirteen patients had a MRS investigation of the brain and the concentration of N-acetyl-aspartate (NAA), choline and creatine was measured and fasting plasma tHcy was assessed. We used linear regression models to investigate the association between tHcy and cerebral metabolic concentrations. Results: We found that tHcy is associated with cerebral NAA (B = -0.09 mmol/l (95% CI, -0.17 to -0.00)) and with creatine (B = -0.09 mmol/l (95% Cl, -0. 16 to -0.02)) per 1 mumol/l increase tHcy. Patients with a tHcy >14 mumol/l had a lower concentration cerebral of NAA (P < 0.05) and creatine (P < 0.01) compared with patients with a tHcy < 14 mumol/l. No significant association was found for the cerebral choline. Conclusion: Elevated levels of tHcy were associated with low concentrations of cerebral NAA and creatine, independent of renal function or the presence of atherosclerotic disease. These preliminary results suggest that tHcy has a neurotoxic effect in vivo. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 16 条
[1]   SPATIAL LOCALIZATION IN NMR-SPECTROSCOPY INVIVO [J].
BOTTOMLEY, PA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :333-348
[2]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[3]   Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic Imaging [J].
Chard, DT ;
McLean, MA ;
Parker, GJM ;
MacManus, DG ;
Miller, DH .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (02) :219-225
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   Homocysteine and brain atrophy on MRI of non-demented elderly [J].
den Heijer, T ;
Vermeer, SE ;
Clarke, R ;
Oudkerk, M ;
Koudstaal, PJ ;
Hofman, A ;
Breteler, MMB .
BRAIN, 2003, 126 :170-175
[6]  
Engelbrecht V, 1997, AM J NEURORADIOL, V18, P536
[7]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[8]   Homocysteine and vascular disease [J].
Hankey, GJ ;
Eikelboom, JW .
LANCET, 1999, 354 (9176) :407-413
[9]   Reproducibility of metabolite concentration evaluated by intraclass correlation coefficient using clinical MR apparatus [J].
Kubo, H ;
Harada, M ;
Sakama, M ;
Nishitani, H .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2003, 27 (03) :449-453
[10]   Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor [J].
Lipton, SA ;
Kim, WK ;
Choi, YB ;
Kumar, S ;
DEmilia, DM ;
Rayudu, PV ;
Arnelle, DR ;
Stamler, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5923-5928